Form 8-K - Current report:
SEC Accession No. 0000950170-25-003811
Filing Date
2025-01-10
Accepted
2025-01-10 08:00:09
Documents
11
Period of Report
2025-01-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K alec-20250109.htm   iXBRL 8-K 36906
  Complete submission text file 0000950170-25-003811.txt   149275

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20250109.xsd EX-101.SCH 24837
13 EXTRACTED XBRL INSTANCE DOCUMENT alec-20250109_htm.xml XML 4686
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 25520492
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)